Teratoma pathophysiology

Jump to navigation Jump to search

Teratoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Teratoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Teratoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Teratoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Teratoma pathophysiology

CDC on Teratoma pathophysiology

Teratoma pathophysiology in the news

Blogs on Teratoma pathophysiology

Directions to Hospitals Treating Teratoma

Risk calculators and risk factors for Teratoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

There have been several theories about the causes of teratoma. Mounting evidence suggests most are due to abnormal differentiation of fetal germ cells that arise from the fetal yolk sac

. Many genetic factors are reported to be involved in pathogenesis of teratomas, mature and immature tumors.

Maternal imprinting of the following genes are likely involved in development of teratomas:

  • , insulin like growth factor 2 (IGF II) and its receptor RNA (H-19)
  • small nuclear riboprotein (SNRPN)
  • mas proto-oncogene
  • tumor suppressor genes WT1

Microsatellite instability is also reported to be involved in pathogenesis of teratomas; however, further evaluation is required to fully understand the underlying mechanism.

For some tumors like sacrococcygeal teratomas, no etiology has been evident yet. Familial predilection is a potential cause for some ovarian derived teratomas.

There have been studies proposing a role of diets high in polyunsaturated fat as a predisposing factor for the growth of teratomas.

Disorders of sex development (DSDs) have also been associated with development of germ cell tumors. Gonadoblastoma, a type of teratoma, is frequently seen in Turner syndrome. Klinefelter syndrome is associated with development of extragonadal malignant germ cell tumors.

References

Template:WH Template:WS